Detalhe da pesquisa
1.
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
Diabetes Obes Metab
; 24(7): 1277-1287, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35322567
2.
Current trends in diabetes mellitus database research in Japan.
Diabetes Obes Metab
; 23 Suppl 2: 3-18, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33835639
3.
Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
Diabetes Obes Metab
; 23 Suppl 2: 19-27, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33835641
4.
Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.
Diabetes Obes Metab
; 23(1): 75-85, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32893440
5.
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
Diabetes Obes Metab
; 22(9): 1607-1618, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32363737
6.
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan.
J Clin Med
; 13(11)2024 May 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38892932
7.
Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.
Sci Rep
; 14(1): 9095, 2024 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38643208
8.
Correction: Kohsaka et al. Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828.
J Clin Med
; 12(7)2023 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37048834
9.
Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia.
J Clin Med
; 11(19)2022 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36233692
10.
Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia.
Nutrients
; 14(21)2022 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36364890
11.
Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study.
Mayo Clin Proc Innov Qual Outcomes
; 5(2): 274-285, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33997627
12.
Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan.
Kidney Med
; 2(6): 742-752.e1, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33319198
13.
Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan.
Kidney Int Rep
; 4(9): 1248-1260, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31517144
14.
Anemia Treatment, Hemoglobin Variability, and Clinical Events in Patients With Nondialysis-Dependent CKD in Japan.
Kidney360
; 4(9): e1223-e1235, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37424063
15.
Spatiotemporal Modeling for Fine-Scale Maps of Regional Malaria Endemicity and Its Implications for Transitional Complexities in a Routine Surveillance Network in Western Cambodia.
Front Public Health
; 5: 262, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29034229
16.
Fine-Scale Mapping by Spatial Risk Distribution Modeling for Regional Malaria Endemicity and Its Implications under the Low-to-Moderate Transmission Setting in Western Cambodia.
PLoS One
; 11(7): e0158737, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27415623